Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
about
Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusChemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionChemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionTreatment of gastric cancerChemotherapy in Elderly Patients with Gastric CancerCytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerRamucirumab: A New Therapy for Advanced Gastric CancerDeveloping and validating risk prediction models in an individual participant data meta-analysisClinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysisThe evolving role of catumaxomab in gastric cancerDetermination of prognostic factors in Japanese patients with advanced gastric cancer using the data from a randomized controlled trial, Japan clinical oncology group 9912.Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction.Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer.The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracilEpirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials.High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancerPreoperative and early postoperative quality of life predict survival in potentially curable patients with esophageal cancer.Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation.Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer.Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient DataPredictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by Chemotherapy.The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients.LRP5 polymorphism-A potential predictor of the clinical outcome in advanced gastric cancer patients treated with EOF regimen.Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.Survival in patients with stage IV noncardia gastric cancer - the influence of DNA ploidy and Helicobacter pylori infection.Recent advances in chemotherapy for advanced gastric cancerChemotherapy for patients with advanced gastric cancer with performance status 2Quality of life predicts survival in patients with non-small cell lung cancerSkin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II studyNeoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
P2860
Q22241762-76ECF14C-223D-4154-851C-BCA3E65FA80DQ24202957-E0FBF1C6-ED8A-433A-AF37-C0E711473B06Q24235532-4BC5FB9E-C5E7-4056-9C43-FA5ED5E9D598Q24244263-09DC0FC3-D375-4919-AC7C-B5C971E8C80DQ24602875-EF038F65-F2A3-49B6-9509-1FDB4D672D6EQ26771424-CA5AEBB3-B747-40FE-B618-9E2ABB371BDDQ26774538-ACB466BD-A473-4FA1-BE86-5D9CBE8C6206Q26785706-188BC321-F413-4102-9B24-0704434BD0BDQ26859694-D305D4A4-FFE9-4782-9A41-FB2E2C6F4B3BQ27496690-BEB8D230-ECEB-4E03-8542-FD7A262CE6B8Q28290511-78469848-EEC6-454F-9FA0-11FEC9B0196FQ30785622-18E3EFDE-79FC-4250-A6A3-1BFC1440346EQ31162395-FE835663-9F18-47DD-B8D2-83103EF2D29BQ33317139-12E59D1A-A596-43CA-8F31-492FB452FA2CQ33380002-AA9FA597-A285-4BF8-8987-93650320D4E9Q33386661-10F6ED5A-B205-4A96-B5E4-550DB8007613Q33398040-D844B291-7BFF-4090-AD63-97B4AEFD4199Q33402388-EC07BFF4-51AF-4F98-904A-9D5A499DF188Q33416469-07762244-7B64-4418-BA3B-D8500E668467Q33416500-0E76F0C9-64A4-4719-9AF4-59B3F25A4B52Q33417940-6D7FC8BD-B311-41C6-80B5-8C3D9443E132Q33420370-4D29B4B3-FD4A-452F-AE62-EBE6E5D6F899Q33428751-5BE4D4AB-39F2-42C7-A669-F2AD22EAA0AFQ33587884-CDFAF5A1-DA7A-4BA5-8E8D-AF477F809BEAQ33596402-8F7C38F2-900C-48D2-B923-E908ECF4C410Q33605930-FC0399DD-ED2E-4F4C-AFC6-B1729F2CBE84Q33658659-80BE4AA0-238D-4667-89C6-6D2AC53DC70CQ33729150-B870D4B6-FB92-4B1B-BA2E-8A25C83BB639Q33849290-70F0763E-EC41-4C13-BC6A-96E1874DDFCAQ33866015-6C3BBF0B-C94B-466D-A774-E02C978238F1Q34059644-84D28907-1634-41BC-8AC7-4065E8F8D272Q34117864-8223B8BB-B533-4F70-A89E-BF1CD9A30616Q34130203-AFC7F924-1C2D-4C03-8456-0D2079E27D45Q34321523-4981F3C2-3A1D-46E9-85F1-108EEF239A5EQ34379588-CA8C9556-F9D4-4027-BE25-F746B1BC0E57Q34389753-4A5B2B1D-8A8B-456C-B761-85FFBF307F5CQ34395962-FA17C248-8AC2-41C2-8BA8-5951772DB2F5Q34414968-706964CC-E539-446F-9FE1-55E94B079E34Q34424047-8A69B4A5-068E-447C-83BD-508868C191A0Q34488692-B217E440-EB67-4B65-8D9F-EEFEC9452D96
P2860
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Multivariate prognostic factor ...... using individual patient data.
@ast
Multivariate prognostic factor ...... using individual patient data.
@en
type
label
Multivariate prognostic factor ...... using individual patient data.
@ast
Multivariate prognostic factor ...... using individual patient data.
@en
prefLabel
Multivariate prognostic factor ...... using individual patient data.
@ast
Multivariate prognostic factor ...... using individual patient data.
@en
P2093
P356
P1476
Multivariate prognostic factor ...... using individual patient data.
@en
P2093
Andy R Norman
Jacqui Oates
Justin S Waters
Paul J Ross
P304
P356
10.1200/JCO.2004.08.154
P407
P577
2004-06-01T00:00:00Z